Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Equity: 2011-2025

Historic Return on Equity for Niagen Bioscience (NAGE) over the last 7 years, with Sep 2025 value amounting to 0.30%.

  • Niagen Bioscience's Return on Equity rose 26.00% to 0.30% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.30%, marking a year-over-year increase of 26.00%. This contributed to the annual value of 0.23% for FY2024, which is 40.00% up from last year.
  • As of Q3 2025, Niagen Bioscience's Return on Equity stood at 0.30%, which was up 2.13% from 0.30% recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Return on Equity registered a high of 0.30% during Q3 2025, and its lowest value of -1.21% during Q2 2022.
  • Its 3-year average for Return on Equity is -0.02%, with a median of -0.05% in 2024.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by 36bps in 2022, then spiked by 90bps in 2023.
  • Quarterly analysis of 5 years shows Niagen Bioscience's Return on Equity stood at -0.81% in 2021, then increased by 6bps to -0.75% in 2022, then spiked by 57bps to -0.18% in 2023, then soared by 39bps to 0.21% in 2024, then rose by 26bps to 0.30% in 2025.
  • Its last three reported values are 0.30% in Q3 2025, 0.30% for Q2 2025, and 0.28% during Q1 2025.